Anna Ressa

发表

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in GBM

M. Lamfers, S. Leenstra, E. D. de Graaf, 2022, bioRxiv.

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies

E. D. de Graaf, M. Altelaar, E. Lips, 2022, bioRxiv.

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma

M. Lamfers, S. Leenstra, E. D. de Graaf, 2022, Frontiers in Oncology.

A system-wide approach to monitor responses to synergistic BRAF and EGFR inhibition in colorectal cancer cells

Edwin Cuppen, Anna Ressa, Anirudh Prahallad, 2017, bioRxiv.

Multiomics profiling of paired primary and recurrent glioblastoma patient tissues

S. Leenstra, T. Luider, J. Kros, 2020, Neuro-oncology advances.

Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities

M. Dowsett, S. Johnston, A. Ressa, 2020, Oncogene.

A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells*

R. Bernards, E. Cuppen, A. Heck, 2017, Molecular & Cellular Proteomics.

PaDuA: A Python Library for High-Throughput (Phospho)proteomics Data Analysis

Anna Ressa, Albert J. R. Heck, Martin Fitzpatrick, 2018, Journal of proteome research.

Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors.

Anna Ressa, Tim S. Veth, Nynke M Kannegieter, 2024, Drug discovery today.